MedCity News
JANUARY 31, 2025
We are living in a moment when many realize that collaboration yields better, faster and more affordable advances. Open source also enables the potential for bigger profits and revenue. Whats in reach: a small amount of money paid for treatments across millions of people, rather than expensive lifesaving treatments only for the few who can afford them.
PharmaVoice
JANUARY 31, 2025
Despite regulatory uncertainty, pharma is bouncing back from a market slump and is being fueled by innovation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
JANUARY 31, 2025
In this episode, were joined by Emily Lindemer, an executive director at Morgan Health. Lindemer discusses a recent report she co-authored, which focuses on maternal health opportunities in employer-sponsored insurance. The post MedCity FemFwd: Comparing Maternal Health in Employer-Sponsored Populations vs. Medicaid appeared first on MedCity News.
Pharmaceutical Technology
JANUARY 31, 2025
The FDA has approved Vertex Pharmaceuticals oral Journavx (suzetrigine) to treat adults with moderate-to-severe acute pain.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
MedCity News
JANUARY 31, 2025
Vertex Pharmaceuticals Jounavx is now FDA approved, providing patients a non-opioid option for treating acute pain. The twice-daily pill is the first in a new class of medicines that block a key pathway in the peripheral nervous system. The post Vertex Pharmas Opioid Alternative Wins FDA Approval, First in a New Class of Pain Meds appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
JANUARY 31, 2025
We kick off our first season of the MedCity Pivot Podcast by discussing ways healthcare organizations can protect themselves from being targets of a cybersecurity attack. A new IEEE Standard can help. The post MedCity Pivot Podcast: Embedding a New Data Safety Standard in Healthcare appeared first on MedCity News.
pharmaphorum
JANUARY 31, 2025
In a shock move, AstraZeneca has ditched its plan to invest 450m in a new vaccine manufacturing plant in the UK.
MedCity News
JANUARY 31, 2025
More effective and proactive care requires a framework that will enable the U.S. healthcare system to better meet the inevitable challenges of an aging population and pave the way for a sustainable and equitable future. Monitoring and other digital health enabled tools are helping to build that framework by offering a new medium for care delivery that can supplement primary care and care management services.
pharmaphorum
JANUARY 31, 2025
Metsera and Maze Therapeutics have become the second and third biotechs to complete an IPO on the Nasdaq this year.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
MedCity News
JANUARY 31, 2025
About one in five in-network claims were denied by insurers of qualified health plans on HealthCare.gov in 2023, according to KFF. There is also wide variation by insurer and state. The post Report: HealthCare.gov Insurers Denied 19% of In-Network Claims in 2023 appeared first on MedCity News.
Pharmaceutical Technology
JANUARY 31, 2025
Roche achieved a sales growth of 7% (3% in CHF) in 2024, citing strong demand for pharmaceutical products.
pharmaphorum
JANUARY 31, 2025
Recent financings in the digital health and AI space include rounds for Rad AI, Eleos, Allara Health, Manas AI, Delfina Care, and Grey Matter Neuro
European Pharmaceutical Review
JANUARY 31, 2025
The National Institute for Health and Care Excellence (NICE) has issued positive final draft guidance for a one-off gene therapy which provides a potential cure for certain patients with severe sickle cell disease. This approval of CASGEVY (exagamglogene autotemcel) is indicated for individuals 12 years and older who have certain types of severe sickle cell disease.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
pharmaphorum
JANUARY 31, 2025
Vertex gets FDA approval for its non-opioid pain drug suzetrigine, the first new class of pain medicine in the US in more than 20 years.
PharmaTech
JANUARY 31, 2025
AI regulations in healthcare are rapidly evolving, and one should consult with regulatory subject matter experts, says Siegfried Schmitt, PhD, vice president, Technical at Parexel.
Pharmaceutical Technology
JANUARY 31, 2025
The CDMO has not disclosed how many employees will be affected by the operational wind down.
Pharmaceutical Commerce
JANUARY 31, 2025
Celltrions Avtozma has been indicated for the treatment of giant cell arteritis, polyarticular juvenile idiopathic arthritis, rheumatoid arthritis, systemic juvenile idiopathic arthritis, and COVID-19in the same dosages and formulations as its tocilizumab reference product.
Advertiser: ZoomInfo
In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.
Pharmaceutical Technology
JANUARY 31, 2025
On 1 January 2025, important legal amendments relating to drug pricing in Germany included in the Medical Research Act came into legal force.
pharmaphorum
JANUARY 31, 2025
Rare diseases often leave patients, healthcare professionals, and pharma companies navigating complex challenges, from limited treatment options to high costs and difficult clinical trial development. Cell and gene therapies (CGT) offer a unique opportunity to address these challenges by treating diseases at their genetic or cellular roots. In this webinar, sponsored by IPG Health, discover how industry insiders are unlocking the potential of CGT in rare disease care, the unique hurdles facing p
Pharmaceutical Technology
JANUARY 31, 2025
CRISPR-based gene therapy Casgevy has been made available to patients with sickle cell disease in England.
PharmaTech
JANUARY 31, 2025
If the conditions prove optimal, 2025 could be a prosperous year for bio/pharma business deals.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Pharmaceutical Technology
JANUARY 31, 2025
The top 20 biopharmaceutical companies experienced mixed performance in 2024 amid a dynamic landscape influenced by various factors.
PharmExec
JANUARY 31, 2025
Clinical trials demonstrated that a single dose of Symbravo provides rapid migraine relief, sustains efficacy for up to 48 hours, and reduces the need for rescue medication.
Pharmaceutical Technology
JANUARY 31, 2025
Daiichi Sankyo has announced that Hiroyuki Okuzawa will succeed Sunao Manabe as chief executive officer from 1 April 2025.
PharmExec
JANUARY 31, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Advertiser: ZoomInfo
As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.
pharmaphorum
JANUARY 31, 2025
Vertex's gene-editing therapy for sickle cell disease, Casgevy, has been given the nod for use by the NHS in England after an earlier rejection
PharmExec
JANUARY 31, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Commerce
JANUARY 31, 2025
In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld value & access advisor for Schoonveld Advisory and author of The Price of Global Health, previews his upcoming February column.
Expert insights. Personalized for you.
318 
Let's personalize your content